etoposide has been researched along with Cancer of Intestines in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Asanuma, K; Fujishima, F; Furukawa, T; Hata, T; Hatta, W; Koike, T; Masamune, A; Saito, M; Unno, M | 1 |
| Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T | 1 |
| Barbera, MA; Biasco, G; Bondi, A; Brandi, G; Brighi, N; Campana, D; Corbelli, J; Pantaleo, MA; Paragona, M | 1 |
| Ali, AS; Grönberg, M; Grønbæk, H; Hjortland, GO; Janson, ET; Knigge, U; Ladekarl, M; Langer, SW; Österlund, P; Sorbye, H; Vestermark, LW; Welin, S | 1 |
| Aldrich, JD; Overman, MJ; Raghav, KPS; Varadhachary, GR; Wolff, RA | 1 |
| Bando-Polaino, I; Cabezas-Camarero, S; de la Orden García, V; Díaz-Rubio, E; García-Barberán, V; Llovet García, P; Mediero-Valeros, B; Merino Menéndez, S; Pérez-Segura, P; Subhi-Issa, AI | 1 |
| Boudreaux, JP; Ramirez, RA; Thiagarajan, R; Thomas, KEH; Voros, BA; Woltering, EA | 1 |
| Mulchandani, M; Sankaranarayanan, A; Tirupati, S | 1 |
| Fazio, N; Milione, M | 1 |
| Covington, A; Hu, S; McCarthy, D; Mojtahed, A; Thompson, W; Volpicelli, N | 1 |
| Chott, A; Friedrich, C; Janka-Schaub, G; Kabisch, H; Schrum, J | 1 |
| Arima, F; Kataoka, I; Kobayashi, Y; Matsuno, Y; Nishimoto, J; Shimoda, T; Tamura, R; Tobinai, K; Watanabe, T; Yamamoto, S | 1 |
| Horiuhi, T; Ichinohasama, R; Nomura, J; Okuda, M | 1 |
| Arai, M; Fujii, H; Kojima, Y; Koyama, F; Matsumoto, H; Mukogawa, T; Nakajima, Y; Takeuchi, T; Yagi, H | 1 |
| Nishimura, J; Ohshima, K; Shiokawa, S; Shiratsuchi, M; Suehiro, Y; Yoshikawa, Y | 1 |
| Chott, A; Drach, J; Hejna, M; Hoffmann, M; Püspök, A; Raderer, M; Wöhrer, S | 1 |
| Hirokawa, M; Lee, M; Miura, AB; Motegi, M | 1 |
2 review(s) available for etoposide and Cancer of Intestines
| Article | Year |
|---|---|
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Intestinal Neoplasms; Irinotecan; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Stomach Neoplasms | 2019 |
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cell Proliferation; Etoposide; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Neoplasm Grading; Pancreatic Neoplasms; Platinum Compounds; Prognosis; Stomach Neoplasms | 2016 |
2 trial(s) available for etoposide and Cancer of Intestines
| Article | Year |
|---|---|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2021 |
Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Intravenous; Intestinal Neoplasms; Leukopenia; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Survival Rate; Treatment Outcome; Vincristine | 2004 |
13 other study(ies) available for etoposide and Cancer of Intestines
| Article | Year |
|---|---|
Duodenal Obstruction Caused by the Long-term Recurrence of Appendiceal Goblet Cell Carcinoid.
Topics: Adult; Antineoplastic Agents; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cisplatin; Colectomy; Duodenal Obstruction; Etoposide; Humans; Intestinal Neoplasms; Japan; Male; Neoplasm Recurrence, Local; Treatment Outcome | 2020 |
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Unknown Primary; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms | 2018 |
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Intestinal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Proportional Hazards Models; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2018 |
Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cetuximab; Cytarabine; ErbB Receptors; Etoposide; Genotype; Humans; Intestinal Neoplasms; Liquid Biopsy; Male; Melphalan; Paranasal Sinus Neoplasms | 2019 |
Clozapine, cancer chemotherapy and neutropenia - dilemmas in management.
Topics: Adult; Antineoplastic Agents; Antipsychotic Agents; Bleomycin; Breast Neoplasms; Carcinoma; Cisplatin; Clozapine; Etoposide; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Schizophrenia; Seminoma; Testicular Neoplasms | 2013 |
Intestinal Lipomatosis and Chemotherapy: A Growing Concern.
Topics: Adult; Anemia, Iron-Deficiency; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Colonoscopy; Etoposide; Humans; Intestinal Neoplasms; Lipoma; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Multiple Primary; Orchiectomy; Testicular Neoplasms | 2016 |
Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Humans; Intestinal Neoplasms; Lymphoma, T-Cell; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasm Staging; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Thioguanine; Vincristine | 2010 |
Enteropathy-type T-cell lymphoma showing repeated small bowel rupture and refractoriness to chemotherapy: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Intestinal Fistula; Intestinal Neoplasms; Intestinal Perforation; Jejunal Diseases; Lymphoma, T-Cell; Male; Prednisone; Rupture, Spontaneous; Vincristine | 2002 |
[Abscopal effect of small intestinal NK/T-cell lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Intestinal Neoplasms; Intestine, Small; Killer Cells, Natural; Lymphoma, T-Cell; Prednisone; Radiotherapy Dosage; Remission Induction; Vincristine | 2003 |
[Anti-CD20 antibody and combination chemotherapy followed by autologous peripheral blood stem cell transplantation after high-dose chemotherapy induced complete remission in a case of multiple lymphomatous polyposis of the gastrointestinal tract].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Administration Schedule; Etoposide; Humans; Intestinal Neoplasms; Intestinal Polyposis; Lymphoma, Mantle-Cell; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Rituximab | 2003 |
Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Humans; Immunophenotyping; Intestinal Mucosa; Intestinal Neoplasms; Intestine, Small; Lymph Nodes; Lymphoma, T-Cell; Male; Methylprednisolone; Neoplasm Invasiveness; Neoplastic Stem Cells; Organ Specificity; Pleural Effusion; Prednisone; Receptors, CCR7; Receptors, Chemokine; T-Lymphocyte Subsets; Vincristine; Viscera | 2004 |
Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin's lymphoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Intestinal Neoplasms; Kidney Diseases; Leukocytosis; Lymphoma, Large B-Cell, Diffuse; Male; Neutropenia; Prednisolone; Recombinant Proteins; Remission Induction; Vinca Alkaloids | 1996 |